Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.78 USD | -1.17% | -5.31% | +113.85% |
04/06 | LadRx Corporation and ImmunityBio, Inc. Mutually Agree to Terminate Aldoxorubicin License | CI |
15/05 | LadRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+113.85% | 1.39M | |
+48.33% | 56.87B | |
+37.15% | 39.72B | |
-5.59% | 39.27B | |
-6.90% | 28.73B | |
+13.30% | 26.21B | |
-15.96% | 19.79B | |
+32.12% | 12.28B | |
+28.25% | 12.23B | |
+0.17% | 12.12B |
- Stock Market
- Equities
- LADX Stock
- News LadRx Corporation
- CytRx Corporation Announces Board Changes